4.3 Article

Multicenter validation of the VITEK MS v2.0 MALDI-TOF mass spectrometry system for the identification of fastidious gram-negative bacteria

Journal

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Volume 78, Issue 2, Pages 129-131

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.diagmicrobio.2013.08.013

Keywords

MALDI-TOF MS; Fastidious; Gram-negative bacilli; Identification; VITEK

Funding

  1. bioMerieux, Inc
  2. bioMerieux
  3. Becton Dickinson
  4. Alere Inc.
  5. Diasorin, Inc.
  6. Accler8
  7. Cepheid
  8. T2 Biosystems
  9. Biofire
  10. Biohelix
  11. Nanosphere
  12. Curetis
  13. Luminex
  14. Bruker
  15. CDC
  16. Forest Laboratories

Ask authors/readers for more resources

The VITEK MS v2.0 MALDI-TOF mass spectrometry system's performance in identifying fastidious gram-negative bacteria was evaluated in a multicenter study. Compared with the reference method (DNA sequencing), the VITEK MS system provided an accurate, species-level identification for 96% of 226 isolates; an additional 1% were accurately identified to the genus level. (C) 2014 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available